Advertisement

Topics

US FDA grants orphan drug status to Chondrial Therapeutics' CTI─1601 to treat Friedreich's Ataxia

07:19 EDT 6 Aug 2017 | PharmaBiz

Chondrial Therapeutics, an emerging biotechnology company focused on the treatment of rare mitochondrial diseases, announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to

Original Article: US FDA grants orphan drug status to Chondrial Therapeutics' CTI─1601 to treat Friedreich's Ataxia

NEXT ARTICLE

More From BioPortfolio on "US FDA grants orphan drug status to Chondrial Therapeutics' CTI─1601 to treat Friedreich's Ataxia"

Quick Search
Advertisement
 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...